180 Life Sciences Corp. (NASDAQ: ATNF)
$1.3200
-0.0900 ( -8.97% ) 82.3K
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Market Data
Open
$1.3200
Previous close
$1.4100
Volume
82.3K
Market cap
$4.48M
Day range
$1.3310 - $1.4700
52 week range
$1.1600 - $17.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 16 | Feb 26, 2024 |
| 8-k | 8K-related | 15 | Feb 20, 2024 |
| 424b3 | Other | 2 | Feb 16, 2024 |
| 8-k | 8K-related | 17 | Feb 16, 2024 |
| 424b3 | Other | 2 | Feb 16, 2024 |
| 424b3 | Other | 2 | Feb 16, 2024 |
| sc | Insider transactions | 1 | Feb 14, 2024 |
| 424b3 | Other | 5 | Feb 12, 2024 |
| effect | Other | 1 | Feb 09, 2024 |
| corresp | Comment letters | 2 | Feb 07, 2024 |